Launch of White Paper, Liver Cancer: No Patient Left Behind Jointly with DiCE
Event description
Hepatocellular Carcinoma (HCC) is the world’s 6th most common cancer and the 3rd most fatal. Every year, more than 98,000 European citizens are diagnosed with liver cancer, while around 89,000 die from the disease
The purpose of the White Paper on Liver Cancer is to assist health-policy makers from across Europe in identifying the key priority areas of unmet needs, with a view to implementing best practices for liver cancer patients, based on the currently available evidence.
The White Paper on Liver Cancer has been developed based on extensive research of recent data, expert consultations, and existing expertise within DiCE and ELPA.
DiCE and ELPA call upon all stakeholders across Europe to work together to ensure that best practices are implemented at every stage of the patient pathway in each country, giving every patient with liver cancer the best possible opportunity of a positive outcome.
Join DiCE and ELPA to increase equality of best practice implementation in the prevention, diagnosis, and management of liver cancer across Europe.